Skip to main content
Premium Trial:

Request an Annual Quote

Anatrace Completes Acquisition of Microlytic

NEW YORK(GenomeWeb) – Protein reagent firm Anatrace has completed its acquisition of Microlytic, which specializes in tools for the structural biology market.

In particular, Microlytic offers products intended to accelerate workflows and improve output quality in soluble protein crystallization.

Anatrace specializes in development and production of high-purity detergents and synthetic lipids for use in membrane protein work. The company is owned by StoneCalibre, a Century City, Calif.-based investment fund.

"With the acquisition of Microlytic we are able to deliver a comprehensive and innovative set of solutions that will further advance the important field of protein biology research," Anatrace CEO Ben Travis said in a statement.

The acquisition follows an October 2014 agreement between the two companies to develop and commercialize a line of products, named Analytic, aimed at membrane protein researchers, and specifically researchers studying high–resolution, three-dimensional protein structures.

Financial and other terms of the acquisition were not disclosed.